Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Meningeal Carcinomatosis 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Chromosome 5q Deletion Syndrome 1

Interventions

Peripheral Blood Stem Cell Transplantation 5fludarabine phosphate 4Busulfan 4Tacrolimus 3Methotrexate 3Mycophenolic Acid 2Filgrastim 2Cyclophosphamide 2Antilymphocyte Serum 2thymoglobulin 1merphos 1fludarabine 1Whole-Body Irradiation 1Spectroscopy, Near-Infrared 1Resistance Training 1Pharmacogenomic Testing 1Oxycodone 1Ondansetron 1Mutation 1Music Therapy 1Moxifloxacin 1Morphine 1Methadone 1Melphalan 1Massage 1Imatinib Mesylate 1Fluorescent Antibody Technique 1Flow Cytometry 1Endoscopy, Digestive System 1Diet, Mediterranean 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Polycythemia Vera × merphos × Clear all
NCT00445744 2018-01-02

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase NA Completed
52 enrolled 7 charts
MyeloidOther hematologic neoplasm

Chromosome 5q Deletion Syndrome, Congenital Abnormalities, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡